Using nationally representative data, the authors found that for common physician-administered drugs, hospitals’ unilaterally set cash prices are frequently lower than their median—and sometimes even ...

Objective: To determine whether industry payments to cardiologists are associated with Medicare beneficiary spending, as financial incentives may influence clinical deci ...

Axsome Therapeutics (NASDAQ:AXSM) executives provided updates on the company’s commercial portfolio and pipeline during a ...

Insurance and health record data showed about 3% of smokers with peripheral artery disease were prescribed the smoking cessation drug, despite the significant benefits of quitting.

In 2019, BMS made a big bet on Sotyktu by deciding to keep the then-pipeline asset despite its pending acquisition of Celgene. Based on that decision, BMS sold its mega-blockbuster Otezla to Amgen for ...

Payer relations executives to know in 2026 are shaping managed care strategies at major health systems and advancing value-based payment models.

Two Michigan health care giants are squaring off in an intensifying reimbursement battle. Michigan Medicine is seeking to maintain its place as the preeminent academic health system in the state with ...

Rhythm’s ColoSTAT blood test for colorectal cancer accredited by The National Association of Testing Authorities ... Read More The post Rhythm wins NATA accreditation for ColoSTAT colorectal cancer ...

CMS’ decision to phase out the inpatient-only list over three years is expected to accelerate the migration of procedures to outpatient settings, particularly ASCs. The policy would eliminate a ...

Zohran Mamdani and Nithya Raman are pursuing a once unthinkable housing alliance: tenant protections paired with pro-market ...

Estefany Maria Rodriguez Flores frequently reports on stories critical of ICE for Noticias, a Spanish-language outlet.

In 2022, Arizona was one of the first states in the nation to pass legislation (House Bill 2144) requiring Medicaid and commercial insurance plans to cover qualified biomarker tes ...